21
Participants
Start Date
August 31, 2010
Primary Completion Date
December 31, 2017
Study Completion Date
August 11, 2020
Super-Selective Intraarterial Intracranial Infusion of Temozolomide
A single dose of Intraarterial Mannitol to open the blood brain barrier followed by Intra-arterial Temozolomide single dose (starting at 75mg/m2 and up to 250mg/m2)
Lenox Hill Brain Tumor Center, New York
Lead Sponsor
Collaborators (1)
Feinstein Institute for Medical Research
OTHER
Hofstra North Shore
OTHER
Northwell Health
OTHER